147 related articles for article (PubMed ID: 34087176)
1. The BAFfling story of MN1-induced leukemogenesis.
Stonestrom AJ; Levine RL
Mol Cell; 2021 Jun; 81(11):2268-2269. PubMed ID: 34087176
[TBL] [Abstract][Full Text] [Related]
2. Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.
Sharma A; Jyotsana N; Gabdoulline R; Heckl D; Kuchenbauer F; Slany RK; Ganser A; Heuser M
Haematologica; 2020 May; 105(5):1294-1305. PubMed ID: 31413090
[TBL] [Abstract][Full Text] [Related]
3. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
[TBL] [Abstract][Full Text] [Related]
4. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
Riedel SS; Lu C; Xie HM; Nestler K; Vermunt MW; Lenard A; Bennett L; Speck NA; Hanamura I; Lessard JA; Blobel GA; Garcia BA; Bernt KM
Mol Cell; 2021 Jun; 81(11):2332-2348.e9. PubMed ID: 33974912
[TBL] [Abstract][Full Text] [Related]
5. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
6. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
[TBL] [Abstract][Full Text] [Related]
7. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.
Sharma A; Yun H; Jyotsana N; Chaturvedi A; Schwarzer A; Yung E; Lai CK; Kuchenbauer F; Argiropoulos B; Görlich K; Ganser A; Humphries RK; Heuser M
Leukemia; 2015 Jan; 29(1):157-68. PubMed ID: 24957708
[TBL] [Abstract][Full Text] [Related]
8. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
10. Meningioma 1 (MN1) expression: refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML).
Aref S; Ibrahim L; Morkes H; Azmy E; Ebrahim M
Hematology; 2013 Sep; 18(5):277-83. PubMed ID: 23394438
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype.
Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Vukovic NS; Pavlovic S; Tosic N
Int J Lab Hematol; 2021 Jun; 43(3):433-440. PubMed ID: 33242229
[TBL] [Abstract][Full Text] [Related]
12. Mapping of MN1 sequences necessary for myeloid transformation.
Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
[TBL] [Abstract][Full Text] [Related]
13. Recurrent high-grade astroblastoma with
Sun D; Liu J; Xiao L; Guan H
Clin Neuropathol; 2023; 42(1):30-39. PubMed ID: 36366964
[TBL] [Abstract][Full Text] [Related]
14. MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression.
Meester-Smoor MA; Janssen MJ; Grosveld GC; de Klein A; van IJcken WF; Douben H; Zwarthoff EC
Carcinogenesis; 2008 Oct; 29(10):2025-34. PubMed ID: 18632758
[TBL] [Abstract][Full Text] [Related]
15. Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13.
Imren S; Heuser M; Gasparetto M; Beer PA; Norddahl GL; Xiang P; Chen L; Berg T; Rhyasen GW; Rosten P; Park G; Moon Y; Weng AP; Eaves CJ; Humphries RK
Blood; 2014 Dec; 124(24):3608-12. PubMed ID: 25339361
[TBL] [Abstract][Full Text] [Related]
16. Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.
Kandilci A; Grosveld GC
Blood; 2009 Aug; 114(8):1596-606. PubMed ID: 19561324
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.
Pardee TS
PLoS One; 2012; 7(8):e43185. PubMed ID: 22905229
[TBL] [Abstract][Full Text] [Related]
18. Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Schwind S; Marcucci G; Kohlschmidt J; Radmacher MD; Mrózek K; Maharry K; Becker H; Metzeler KH; Whitman SP; Wu YZ; Powell BL; Baer MR; Kolitz JE; Carroll AJ; Larson RA; Caligiuri MA; Bloomfield CD
Blood; 2011 Oct; 118(15):4188-98. PubMed ID: 21828125
[TBL] [Abstract][Full Text] [Related]
19. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
